Physician profile
Mark Block
NPI 1720071228
$3,330.31
in general payments reported to CMS, 2019-2025
9 companies · $1,959 in 2025
The $1,959 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.50 · 2021: $270 · 2022: $447 · 2023: $24.97 · 2024: $614 · 2025: $1,959.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,309 · Food and Beverage: $1,169 · Gift: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,308.64 |
| Food and Beverage | $1,169.40 |
| Gift | $120.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pleural Dynamics INC. | $1,925.55 | 2025 | Automatic Continuous Effusion Shunt (Aces) System |
| Intuitive Surgical, INC. | $495.47 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $318.64 | 2021-2024 | Opdivo |
| Ethicon INC. | $313.99 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $220.41 | 2021-2022 | |
| Smith+Nephew, INC. | $22.63 | 2022 | |
| Tempus Ai, INC | $18.12 | 2025 | Xt Cdx |
| Angiodynamics, INC. | $15.50 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Block listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.